Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
5
×
clinical trials
drugs
life sciences
national blog main
alnylam pharmaceuticals
boston
boston blog main
boston top stories
patisiran
rna interference
san francisco
san francisco blog main
san francisco top stories
acute hepatic porphyrias
akcea therapeutics
akin akinc
aminolevulinic acid
archive
barry greene
biotech
boston university
cancer
cannabidiol
co-founder
credo ventures
dan ollendorf
disease
dravet syndrome
epidiolex
esther dyson
ezra
fen-phen
fenfluramine
gal
givosiran
gw pharmaceuticals
hereditary transthyretin amyloidosis
inotersen
insurance
What
ago
5
×
fda
medicine
alnylam
drug
pharmaceuticals
rna
weeks
accurate
advisory
approval
approve
approved
awaits
battle
biggest
biological
blame
body
cancer
cancers
cannabis
cdc
company
company’s
crossed
data
decades
decision
declared
derivative
detect
discovered
disease
earlier
emi
epilepsy
eradicated
ezra
fast
Language
Current search:
ago
×
fda
×
@techcrunch.com
4 years ago
Using full-body MRIs, Ezra can now detect 11 cancers in men and 13 in women
@slashgear.com
5 years ago
Don’t blame the measles vaccine for global outbreaks
@xconomy.com
5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision
@xconomy.com
5 years ago
Zogenix Epilepsy Data Sets Up Market Battle With GW’s Cannabis Drug